Inamed To Carry On Quest For Silicone Implant Approval After Panel Rejection
This article was originally published in The Gray Sheet
Executive Summary
Inamed's 20% rupture rate for reconstruction breast implants would drop with the removal of the Style 153 double-lumen implants, according to members of FDA's General & Plastic Surgery Devices Panel
You may also be interested in...
Inamed Receives Silicone Breast Implant “Approvable” Letter From FDA
Inamed's silicone gel-filled breast implants inched closer to the market with the receipt of an FDA "approvable" letter, after the firm removed the controversial Style 153 implants from its PMA application
Inamed Receives Silicone Breast Implant “Approvable” Letter From FDA
Inamed's silicone gel-filled breast implants inched closer to the market with the receipt of an FDA "approvable" letter, after the firm removed the controversial Style 153 implants from its PMA application
Inamed’s Amended Silicone Breast Implant PMA Sheds Style 153 Model
Inamed expects its modified silicone breast implant premarket approval application to receive FDA approval by the end of the summer